Bruker is three-time winner of the iF DESIGN AWARD 2019

Munich, Germany – March 15th, 2019 – Bruker has been awarded the iF DESIGN AWARD for three different products ranking them among the most innovative instrumentation designers. Prizes were awarded to the FT-IR spectrometers INVENIO and ALPHA II as well as to the FT-NIR spectrometer MPA II in the categories “Industry” and “Medicine/Health” of the discipline “Product Design”.... Read more

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow specific to... Read more

Agilent Receives Prestigious Gartner Inc. Power of the Profession Award 2019 for Talent Payback of the Year

Agilent Receives Prestigious Gartner Inc. Power of the Profession Award 2019 for Talent Payback of the Year Recognition for innovative manufacturing and supply-chain training program SANTA CLARA, Calif., March 12, 2019 Agilent Technologies Inc. (NYSE:A) today announced that it has received a Gartner Inc. Power of the Profession Award in the category of Talent Payback... Read more

Xylem to attend 2019 Boenning & Scattergood Water Summit

RYE BROOK, N.Y.–(BUSINESS WIRE)–Mar. 11, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its President and Chief Executive Officer, Patrick Decker, and Senior Director of Investor Relations, Matt Latino, will participate in small group meetings at the 2019 Boenning &... Read more

QIAGEN announces 20-F annual report filing for 2018 results

Germantown, Maryland, and Hilden, Germany, March 6, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2018, with the U.S. Securities and Exchange Commission. The document can be accessed on... Read more

Bio-Techne Scores a Trio of CiteAb 2019 Awards

MARCH 05, 2019 MINNEAPOLIS, March 5, 2019 /PRNewswire/ — Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, was honored with three prestigious 2019 CiteAb Awards. The CiteAb Awards celebrate the very best suppliers and individuals in the research sector worldwide.  Bio-Techne’s Advanced Cell Diagnostics (ACD) brand received... Read more

Colin McCracken Joins Fluidigm as Chief Commercial Officer

SOUTH SAN FRANCISCO, Calif., March 05, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced that Colin McCracken has joined the company as its Chief Commercial Officer. McCracken will be responsible for leading all commercial activities, driving revenue growth in new and existing markets and expanding the company’s global reach. As a member of the executive leadership team reporting to President... Read more

BD to Present at the Barclays Global Healthcare Conference

FRANKLIN LAKES, N.J., March 4, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Tuesday, March 12, 2019, at 2:05 p.m. ET. A live webcast of BD’s presentations can be accessed from the BD corporate website... Read more